文献速递乳腺癌放疗

老年早期乳腺癌术后单次加速部分乳腺照射的早期临床结局

Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome.
PubMed 文献 · Radiat Oncol · 2018-09-12

单中心回顾性队列研究分析48例(51处病灶)≥65岁低危乳腺癌患者,术后接受单次16 Gy多导管组织间高剂量率近距离放疗(MIB)加速部分乳腺照射(APBI)。中位随访40个月,3年局部无复发生存率、特异性生存率和总生存率分别为100%、100%和93.1%,无≥3级晚期毒性,优良美容效果率为76.4%。

要点

  • 48例老年早期乳腺癌患者术后接受单次16 Gy MIB APBI,中位随访40个月无局部复发。
  • 3年局部无复发生存率100%、特异性生存率100%、总生存率93.1%。
  • 3例(6.3%)出现3级急性毒性,无≥3级晚期毒性,优良美容效果率76.4%。

核心结论

  • 作者报告老年患者术后单次MIB APBI的临床结局令人鼓舞,认为单次APBI可作为术中放疗的有吸引力的替代方案,前提是全部患者根据术后病理报告均为APBI的良好候选者。
  • 作者指出需要更成熟的结果(患者数量和随访时间)。

研究设计与样本

  • 单中心回顾性队列研究,纳入≥65岁、低危乳腺癌、接受肿块切除加腋窝评估后行MIB的患者。
  • 处方为单次16 Gy,按100%等剂量线给予。
  • 2012年1月至2015年8月共治疗48例女性(51处病灶),中位年龄77.7岁(范围65-92岁),中位肿瘤大小12 mm(范围3-32 mm)。

主要发现

  • 5例患者存在腋窝淋巴结受累(4例Nmic,1例N1),浸润性导管癌为最常见组织学类型(86.3%)。
  • 中位随访40个月(范围36-42个月),无局部复发,1例(2.1%)发生腋窝复发。
  • 3年局部无复发生存率、特异性生存率和总生存率分别为100%、100%和93.1%。
  • 共记录45起急性事件,最常见急性毒性为1级色素沉着(26.7%),3例(6.3%)出现3级急性毒性(2例乳腺血肿,1例乳腺脓肿)。
  • 未观察到≥3级晚期毒性,共发生15起晚期毒性(1级13起,占86.7%),主要为乳腺纤维化;优良美容效果率为76.4%。

关键数值与推荐

  • 单次16 Gy处方于100%等剂量线。
  • 3年局部无复发生存率100%、特异性生存率100%、总生存率93.1%。
  • 3级急性毒性3例(6.3%),无≥3级晚期毒性,优良美容效果率76.4%。

临床怎么用

  • 作者认为单次MIB APBI是老年低危乳腺癌术后一种有吸引力的术中放疗替代方案,前提是全部患者根据术后病理报告均为APBI的良好候选者。
  • 作者指出需要更成熟的结果(患者数量和随访时间)。

局限性

  • 作者指出需要更成熟的结果(患者数量和随访时间)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To analyze the clinical outcome of elderly women with early breast cancer who underwent accelerated partial breast irradiation (APBI) based on a post-operative single fraction of multicatheter interstitial high dose-rate brachytherapy (MIB). METHODS: A single institution retrospective cohort study was performed focusing on elderly patients (≥ 65 years old) presenting a low-risk breast carcinoma treated by lumpectomy plus axillary evaluation followed by MIB. A single fraction of 16 Gy was prescribed on the 100% isodose. Clinical outcome at 3 years was reported based on local relapse free survival (3-y LRFS), specific survival (SS) and overall survival (OS). Acute (< 180 days after APBI) and late toxicity were evaluated. Cosmetic results were clinically evaluated by the physician. RESULTS: Between January 2012 and August 2015, 48 women (51 lesions) were treated. Median age was 77.7 years (range: 65-92) with a median tumor size of 12 mm (range: 3-32). Five patients (pts) presented an axillary lymph node involvement (4 Nmic, 1 N1). Invasive ductal carcinoma was the most frequent histology type (86.3%). With a median follow-up of 40 months (range: 36-42), no local relapse occurred while 1 pt. developed axillary relapse (2.1%). The 3-y LRFS, SS and OS rates were 100%, 100% and 93.1% respectively. Forty-five acute events were remained. The most frequent acute toxicity was grade (G) 1 hyperpigmentation (26.7%), 3 pts. (6.3%) presented G3 acute toxicity (2 breast hematomas, 1 breast abscess). No ≥ G3 late toxicity was observed while 15 late toxicities occurred (G1: 13 events - 86.7%) mainly breast fibrosis). The rate of excellent cosmetic outcome was 76.4%. CONCLUSION: We reported promising and encouraging clinical outcome of a post-operative single fraction of MIB ABPI in the elderly. This approach leads to consider a sfAPBI as an attractive alternative to intra-operative radiation therapy while all the patients will be good candidates for APBI in regards to the post-operative pathological report. More mature results (number of patients and follow-up) are needed.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kinj R, Chand ME, Gal J, et al. Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome. Radiat Oncol. 2018. PMID: 30208914. doi:10.1186/s13014-018-1119-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。